Heartland Group (HGH) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
25 Feb, 2026Executive summary
Net profit after tax for H1 FY26 was NZD 48.8 million, a significant turnaround from the prior year, with underlying NPAT of NZD 46.1 million and underlying ROE up 540 basis points to 7.3%.
Average NIM expanded 51 basis points to 3.92%, and cost to income ratio reduced by 304 basis points to 54.6%.
Strong Reverse Mortgage growth in both New Zealand and Australia, supported by technology investment and NSA realization.
Interim dividend declared at NZD 0.035 per share, up NZD 0.015 from H1 FY25, with a payout ratio of 72%.
Substantial progress in divesting non-strategic assets and focusing on core lending portfolios.
Financial highlights
Net operating income increased by NZD 15.4 million year-over-year; net interest income rose to $165.9 million from $149.1 million.
Impairment expense ratio dropped to 0.35%, a reduction of 105 basis points year-over-year; impaired asset expense fell to $12.8 million from $50.5 million.
Cost to income (CTI) ratio reduced to 54.6%; underlying EPS was 4.9 cps, up 4.5 cps year-over-year.
Aggregate receivables grew AUD 157 million, 4.3% annualized; total assets grew to $8.81 billion.
Earnings per share increased to 5.20 cents from 0.40 cents year-over-year.
Outlook and guidance
Affirmed FY26 guidance for underlying ROE of at least 7% and underlying NPAT of at least NZD 85 million.
NZ Banking NPAT expected to exceed $45 million, AU Banking NPAT to exceed AU$37 million (NZ$40 million).
NIM and asset quality improvements support positive adjustments to FY26 impairment expense ratio guidance.
Group continues to focus on simplifying its portfolio and redeploying capital into higher-return core lending.
Regulatory capital requirements for the banking group will be reduced effective 1 March 2026.
Latest events from Heartland Group
- NPAT fell short on higher provisions, but receivables and assets grew with strategic expansion.HGH
H2 202423 Jan 2026 - Profit fell on higher impairments, but underlying growth and margin expansion remain positive.HGH
H1 202523 Dec 2025 - Reset year delivers $46.9m profit; FY2026 targets higher ROE, profit, and core growth.HGH
H2 202523 Nov 2025 - Strategic reset, financial rebound, and digital focus drive growth and efficiency.HGH
AGM 202513 Nov 2025 - Lower profit but strong receivables growth and strategic transformation set the FY2028 path.HGH
AGM 202413 Jun 2025